Johnson and Johnson hold millions of lives hostage: restricting the distribution of life saving generic drug
“Multidrug resistant tuberculosis is a growing threat, and bedaquiline is essential to curing it. Generic bedaquiline will drive down the cost of the drug by over 60%, allowing far more communities to access and distribute treatment. Evergreening the patent will cost so many lives over the next four years, which Johnson &...
![](https://kbin.cafe/media/cache/resolve/entry_thumb/74/23/74235fee04d1026f3d8c2a1b0e85c3ebd89854e6677fe1d2f14e0d36114645d9.jpg)